✦ LIBER ✦

Assessment of the effectiveness and safety of natalizumab for treating relapsing-remitting multiple sclerosis

✍ Scribed by M.J. Fernández-Megía; B. Casanova; M.J. Magraner; I. Font-Noguera; J.L. Poveda-Andrés

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cochrane Database of Systematic Reviews

✍ Pucci, Eugenio 📂 Article 📅 2011 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 747 KB

Effect of natalizumab on oxidative damag

✍ Tasset, Inmaculada; Bahamonde, Carmen; Agüera, Eduardo; Conde, Cristina; Cruz, A 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 277 KB

Effect of natalizumab on clinical and ra

✍ Eva Havrdova; Steven Galetta; Michael Hutchinson; Dusan Stefoski; David Bates; C 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 170 KB

Efficacy, safety, and cost-effectiveness

✍ Boster, A.; Bartoszek, M. P.; O'Connell, C.; Pitt, D.; Racke, M. 📂 Article 📅 2011 🏛 SAGE Publications 🌐 English ⚖ 160 KB

Safety, Tolerability, and Efficacy of Or

✍ Oh, Jiwon; OâConnor, Paul W. 📂 Article 📅 2013 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 462 KB

Natalizumab is effective as second line

✍ N. Putzki; K. Kollia; S. Woods; E. Igwe; H. C. Diener; V. Limmroth 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB